Filing Flows › Vistagen Therapeutics (VTGN) › How it makes money
How Vistagen Therapeutics (VTGN) makes money
Vistagen Therapeutics (VTGN) made $1.5M of revenue in the first quarter fiscal 2027 (Q1 FY27), +505% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q1 FY27 | % of revenue |
|---|---|---|
| Revenue | $1.5M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 FY27 | $1.5M | +505% |
| Q4 FY26 | $465K | — |
| Q3 FY26 | $303K | +30% |
| Q2 FY26 | $258K | +41% |
| Q1 FY26 | $244K | +190% |
| Q3 FY25 | $234K | -43% |
From Vistagen Therapeutics' 10-Q filed Aug 14, 2026 (on EDGAR).
Questions
How does Vistagen Therapeutics make money?
Vistagen Therapeutics (VTGN) made $1.5M of revenue in the first quarter fiscal 2027 (Q1 FY27), +505% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.